美国 - 英文 - NLM (National Library of Medicine)

jomex international llc - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz) - bismuth subsalicylate 262 mg in 15 ml - upset stomach reliever and antidiarrheal uses    relieves  • diarrhea  • heartburn  • indigestion  • nausea  • upset stomach

美国 - 英文 - NLM (National Library of Medicine)

lake erie medical & surgical supply dba quality care products llc - mexiletine hydrochloride (unii: 606d60is38) (mexiletine - unii:1u511hhv4z) - mexiletine hydrochloride 150 mg

美国 - 英文 - NLM (National Library of Medicine)

ingenus pharmaceuticals, llc - mexiletine hydrochloride (unii: 606d60is38) (mexiletine - unii:1u511hhv4z) - mexiletine hydrochloride capsules, usp are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. because of the proarrhythmic effects of mexiletine, its use with lesser arrhythmias is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of mexiletine treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias. mexiletine hydrochloride capsules are contraindicated in the presence of cardiogenic shock or pre-existing second- or third-degree av block (if no pacemaker is present).

美国 - 英文 - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - mexiletine hydrochloride (unii: 606d60is38) (mexiletine - unii:1u511hhv4z) - mexiletine hydrochloride 150 mg - mexiletine hydrochloride capsules are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. because of the proarrhythmic effects of mexiletine, its use with lesser arrhythmias is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of mexiletine treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias. mexiletine hydrochloride capsules are contraindicated in the presence of cardiogenic shock or preexisting second- or third-degree av block (if no pacemaker is present).

美国 - 英文 - NLM (National Library of Medicine)

avkare - mexiletine hydrochloride (unii: 606d60is38) (mexiletine - unii:1u511hhv4z) - mexiletine hydrochloride 150 mg - mexiletine hydrochloride capsules usp are indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening. because of the proarrhythmic effects of mexiletine, its use with lesser arrhythmias is generally not recommended. treatment of patients with asymptomatic ventricular premature contractions should be avoided. initiation of mexiletine treatment, as with other antiarrhythmic agents used to treat life-threatening arrhythmias, should be carried out in the hospital. antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias. mexiletine hydrochloride capsules are contraindicated in the presence of cardiogenic shock or pre-existing second-or third-degree av block (if no pacemaker is present).

葡萄牙 - 葡萄牙文 - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

laboratórios azevedos - indústria farmacêutica, s.a. - bromexina - xarope - 0.8 mg/ml - bromexina, cloridrato 0.8 mg/ml - bromhexine - genérico - duração do tratamento: curta ou média duração

葡萄牙 - 葡萄牙文 - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

laboratórios azevedos - indústria farmacêutica, s.a. - bromexina - xarope - 0.8 mg/ml - bromexina, cloridrato 0.8 mg/ml - bromhexine - genérico - duração do tratamento: curta ou média duração

葡萄牙 - 葡萄牙文 - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

laboratórios azevedos - indústria farmacêutica, s.a. - bromexina - xarope - 1.6 mg/ml - bromexina, cloridrato 1.6 mg/ml - bromhexine - n/a - duração do tratamento: curta ou média duração

葡萄牙 - 葡萄牙文 - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

laboratórios azevedos - indústria farmacêutica, s.a. - bromexina - xarope - 1.6 mg/ml - bromexina, cloridrato 1.6 mg/ml - bromhexine - n/a - duração do tratamento: curta ou média duração

葡萄牙 - 葡萄牙文 - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

laboratórios azevedos - indústria farmacêutica, s.a. - bromexina - xarope - 1.6 mg/ml - bromexina, cloridrato 1.6 mg/ml - bromhexine - n/a - duração do tratamento: curta ou média duração